BIOTECHNOLOGY

Study Gives FluMist Clean Bill

In its first two years on the market, Gaithersburg-based MedImmune's nasal-spray flu vaccine has not shown any serious unexpected risks when used as directed, according to a study published yesterday in the Journal of the American Medical Association.

The vaccine has nonetheless suffered from disappointing sales, largely because it is approved for only those ages 5 to 49. MedImmune is conducting studies to persuade federal health officials to approve FluMist for even younger children.

LEGAL

RIM Not Negotiating Patent Suit, Rival Says

Research in Motion is not negotiating to settle a patent suit that could shut down its BlackBerry e-mail service in the United States, said a founder of the patent's owner, McLean-based NTP.

RIM could be forced to shut down U.S. service because NTP won an infringement verdict and efforts to settle the case fell apart.

MERGERS & ACQUISITIONS

RCN to Buy N.Y. Fiber-Optics Utility

Consolidated Edison, owner of New York City's largest utility, said it agreed to sell its money-losing telecommunications business to Herndon-based RCN for about $32 million in cash.

The sale of Consolidated Edison Communications Holding, which operates a fiber-optic cable network, is expected to close in the first quarter of 2006, pending regulatory approval.

Compiled from staff and news service reports.